Other languages ZIVO Bioscience, Inc.

Equities

ZIVO

US98978N3098

Delayed OTC Markets Other stock markets 19:43:36 30/04/2024 BST			5-day change	1st Jan Change
7.9 ^USD	+20.61%		-2.47%	+558.33%

03-15	ZIVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
02-07	ZIVO Bioscience, Inc. Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ZIVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-15
ZIVO Bioscience, Inc. Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study	02-07
Zivo Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens	01-23
ZIVO Bioscience, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13
Zivo Bioscience Insider Bought Shares Worth $199,600, According to a Recent SEC Filing	30/10/23
Zivo Says Trial Results Confirm Efficacy of Non-Antibiotic Product Candidate for Treating Coccidiosis in Broiler Chickens	19/09/23
Trial Results Confirm Efficacy of ZIVO Bioscience?s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens	19/09/23
ZIVO Bioscience, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
Zivo Bioscience, Inc. Commences Sales of Its Proprietary Algal Biomass as Human Food	26/07/23
Zivo Biosciences to Raise $4 Million From Registered Direct Offering, Concurrent Private Placement; Shares Drop	30/06/23
Zivo Bioscience, Inc. Announces its GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as Human Food Ingredient	30/05/23
ZIVO Bioscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	10/05/23
Sector Update: Health Care Stocks Advance Premarket Thursday	06/04/23
Sector Update: Health Care	06/04/23
Top Premarket Decliners	06/04/23
Zivo Bioscience Obtains $1 Million Bridge Financing	05/04/23
ZIVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14/03/23
ZIVO Bioscience, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	14/03/23
ZIVO Bioscience, Inc. Auditor Raises 'Going Concern' Doubt	13/03/23
Top Premarket Decliners	13/02/23

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages ZIVO Bioscience, Inc.

Equities

ZIVO

US98978N3098

Other languages

Filters